Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Change to the Executive Management Committee
-
Preliminary data on early redemptions (prepayments)
-
ZEROUM Inc. Establishes Subsidiary in South Korea, Expands into Asia
-
Change in number of shares and votes in Immunovia AB (publ)
-
Cargotec has completed share repurchases announced in August
-
Foreign media guests explore beauty and culture of Guizhou
-
Tea for Menstrual Cramps: A Soothing Remedy for Relief
-
The Wake Up Project: A Musical Call to Action for Change and Voting Awareness
-
Fujitsu launches "Takane" - A large language model for enterprises offering the highest Japanese language proficiency in the world
-
OKX Wallet Now Supports Why Token for Single- and Cross-Chain Transactions
-
Mindpeak secures $15.3M in series A funding to accelerate growth in AI-based digital pathology
-
NNIT A/S: ATP choses NNIT as new supplier of business-critical SAP system
-
Syensqo announces €300 million share buyback program
-
Share repurchase programme
-
Announcement of change in the total number of votes in AB SKF
-
Autoliv Retires Repurchased Shares, Decreases Number of Issued Shares
-
New number of shares and votes in Sobi
-
Hilbert Group AB (publ) has Carried out a Directed Issue of SEK 20 Million
-
Alejandro Corominas Menéndez appointed President and CEO of Loomis Europe and Latin America
-
Photocure Partner Asieris Unveils Cevira (APL-1702) Phase III Subgroup Analysis by Age Groups at the 2024 CSCO Annual Meeting
-
Depixus Unveils MAGNA One: World’s First Laboratory Instrument for Analyzing Individual Biomolecular Interactions at Scale
-
Exor Press Release - Periodic Report on the Buyback Program
-
Modalis Therapeutics: FDA Grants Rare Pediatric Disease Designation to MDL-101 for the Treatment of Congenital Muscular Dystrophy Type 1a (LAMA2-CMD)
-
BioSenic announces that it has started to look for new assets, the securing of its financing for the coming months by means of an amendment to its convertible bond contract, a change to the compositio
-
Pioneering GeneTree Nano-Crystalline Ceramic Core: Debuting the First High-Capacity, High-Wattage Solution in Vape Industry
-
Olympus Launches VISERA S, a New Imaging Platform
-
InterContinental Hotels Group PLC Announces Transaction in Own Shares - Sept 30
-
Genflow Biosciences PLC Announces Half-year Report
-
Touchstone Exploration Announces Cascadura Well Test Results and Provides an Operational Update
-
Thor Issues Response to Press Speculation
-
CME Group to Expand Battery Metals Suite with Launch of Spodumene Futures on October 28
-
SOFTSWISS Presents Three Innovative Products in South Africa
-
Best's Market Segment Report: MENA Reinsurer Performance Benefits from Pricing Environment, Higher Interest Rates
-
MSTX, The First Leveraged MicroStrategy ETF in the U.S. Surpasses $400 Million
-
GoldenPeaks Capital and CNBM Strengthen Their Renewable Energy Partnership and Commit to Target a 1GW Project Pipeline Annually in Europe
-
Syngenta Group Adds Cutting-Edge Generative Artificial Intelligence (GenAI) to Cropwise
-
Caledonia Mining Corporation Plc: Notification of relevant change to significant shareholder
-
Verona Pharma to Present Six Analyses of the Phase 3 ENHANCE Studies in COPD at CHEST 2024
-
Half-Yearly Results
-
Dékuple: 2024 FIRST-HALF EARNINGS
-
RIBER receives order to equip an autonomous pilot line for the design and manufacturing of optical devices in Europe
-
Fingerprint Cards AB (publ): Increase in number of B shares and votes
-
DENSO Announces Changes of Executive Responsibility and Executive Officers
-
Tetragon Financial Group Limited August 2024 Monthly Factsheet
-
China Eastern Airlines Launches Direct Flights From Shanghai to Venice and Xi'an to Milan
-
IASO Bio Scientist and Leading Chinese Physicians in Onco-Hematology Visit Hematology Center at the State University of Campinas, Brazil, to Explore Cooperation in Cancer Treatment
-
Inside information: Karri Alameri appointed as the CEO of Oma Savings Bank Plc
-
Akeso's Cadonilimab Receives Second Indication Approval from NMPA for First-Line Treatment of Gastric/GEJ Cancer in All-Comers Population
-
Stellantis Updates 2024 Financial Guidance
-
Stellantis Updates 2024 Financial Guidance
